Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Bratisl Lek Listy ; 120(1): 40-45, 2019.
Article in English | MEDLINE | ID: mdl-30685991

ABSTRACT

OBJECTIVE: We aimed to investigate the vasoactive effects of dexmedetomidine on isolated human umbilical arteries and possible mechanisms involved. METHODS: Human umbilical artery strips were suspended in Krebs-Henseleit solution and dose-response curves were obtained for cumulative dexmedetomidine before and after incubation with different agents; propranolol, atropine, yohimbine, prazosin, indomethacin, verapamil. Effects of calcium on cumulative dexmedetomidine-induced contractions were also studied. RESULTS: Cumulative dexmedetomidine resulted in dose dependent contraction responses. Incubation with propranolol (Emax: 93.3 ± 3.26 %), atropine (Emax: 92.0 ± 6.54 %), or indomethacin (Emax: 94.25 ± 2.62 %), did not attenuate dexmedetomidine-elicited contractions (p > 0.05). There were significant decreases in the contraction responses of cumulative dexmedetomidine with yohimbine (Emax: 12.1 ± 11.9 %), prazosin (Emax: 28.8 ± 4.6 %) and verapamil (Emax: 11.2 ± 13.6 %) (p < 0.05). In Ca+2 free medium contraction responses to cumulative dexmedetomidine was insignificant (Emax: 5.20 ± 3.42 %). Addition of cumulative calcium to the Ca+2 free medium resulted in concentration dependent increase in contractions (Emax: 64.83 ± 37.7 %) (p < 0.05). CONCLUSION: Dexmedetomidine induces vasoconstriction in endothelial-free umbilical arteries via both, α1- and α2-adrenergic receptors and also extracellular Ca+2 concentrations play a major role. ß-adrenergic receptors, muscarinic cholinergic receptors, and inhibition of cyclooxygenase enzyme are not involved in this vasoconstriction (Fig. 3, Ref. 36).


Subject(s)
Analgesics, Non-Narcotic , Dexmedetomidine , Vasoconstriction , Analgesics, Non-Narcotic/pharmacology , Calcium , Dexmedetomidine/pharmacology , Humans , In Vitro Techniques , Muscle Contraction/drug effects , Muscle, Smooth, Vascular , Umbilical Arteries , Vasoconstriction/drug effects
2.
Clin Exp Obstet Gynecol ; 42(3): 392-4, 2015.
Article in English | MEDLINE | ID: mdl-26152022

ABSTRACT

Cantrell's pentalogy (CP) is a rare syndrome characterized by defects in the lower sternum with ectopia cordis, anterior diaphragm defects, midline supraumbilical abdominal wall defects, defects in the diaphragmatic pericardium, and congenital heart disease. The authors report a 12-weeks gestation with multiple fetal anomalies suggesting the diagnosis of CP (a large thoraco-abdominal defect with herniating liver and bowel, heart deviated anteriorly with concomitant ventricular septal defect), and the 'S' shaped fetal spine due to increased lumbar lordosis and scoliosis with accompanying pes equinovarus deformity. Chorionic villus sampling was performed due to increased nuchal translucency (3.7 mm). The fetal karotype was found to be 47, XX,+21 (trisomy 21). In the literature, three scoliosis cases have been reported accompanying the CP along with multiple anomalies and one concomitant pes equinovarus deformity has been reported previously.


Subject(s)
Abnormalities, Multiple/diagnosis , Clubfoot/diagnosis , Down Syndrome/genetics , Heart Defects, Congenital/diagnosis , Pentalogy of Cantrell/diagnosis , Scoliosis/diagnosis , Abortion, Induced , Chorionic Villi Sampling , Female , Gestational Age , Humans , Pregnancy , Pregnancy Trimester, First , Ultrasonography, Prenatal , Young Adult
3.
Gynecol Endocrinol ; 31(6): 477-82, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26213862

ABSTRACT

This study explores the relationship between clinical cardiovascular risk factors and clinical androgen excess, with direct comparison to radial artery intima media thickness (rIMT). rIMT of 91 patients with polycystic ovary syndrome (PCOS) were compared with 72 healthy women. Patients were divided into three groups with regard to body mass index (BMI). Group1 = 56 women (31 controls and 25 PCOS) with low BMI(18-22.49 kg/m(2)), Group2 = 36 women (15 controls and 21 PCOS) with normal BMI (22.5-24.99 kg/m(2)) and Group3 = 71 women (26 controls and 45 PCOS) with high BMI (25-30 kg/m(2)). rIMT was significantly higher in patients with PCOS (p = 0.007). rIMT was significantly higher group1 and group3 in patients with PCOS compared to controls (p = 0.007 and p = 0.042, respectively). There was a significant positive association between rIMT levels and fT in women with PCOS in group1 (r = 0.24, p = 0.04). rIMT levels correlated to fT levels in women with PCOS in group3 (r = 0.32, p = 0.03). Modified Ferriman-Gallwey (mFG) scores demonstrated a positive association with free testosterone, total testosterone, free androgen index, waist circumference (WC), LH levels, insulin levels, Homeostasis Model Assessment index(HOMA-IR), rIMT and a negative correlation with sex hormone binding globulin in group1 and group2. mFG scores demonstrated a positive association with free testosterone (r = 0.33, p = 0.029) in group3, but no association was found between mFG and WC, HOMA-IR in group3. Our findings indicate that clinical androgen excess may be associated with cardiovascular disease in patients with PCOS.


Subject(s)
Androgens/blood , Carotid Intima-Media Thickness , Polycystic Ovary Syndrome/blood , Polycystic Ovary Syndrome/diagnostic imaging , Radial Artery/diagnostic imaging , Adult , Female , Humans , Young Adult
4.
Eur J Gynaecol Oncol ; 36(1): 59-61, 2015.
Article in English | MEDLINE | ID: mdl-25872336

ABSTRACT

PURPOSE: To describe the clinical and histopathological characteristics of 12 patients with pyometra and highlight the increased incidence of gynecological malignancy in these patients. MATERIALS AND METHODS: The authors examined the medical records of 12 patients with pyometra, who were treated between 2009 and 2013. RESULTS: All patients were post-menopausal, and their mean age was 70.83 ± 6.978 years (min = 61, max = 82). To remove purulent fluid via dilation and because of the probability of malignancy, three patients (25%) underwent cervical biopsy and endometrial curettage; the other nine patients (75%) underwent curettage alone, with suitable antibiotic therapy. Of the 12 patients, nine (75%) had gynecologic malignancy [(endometrial cancer, n = 5, 41.6%), (cervical cancer, n = 3, 25%), (uterine leiomyosarcoma, n = 1, 8.3%)]. In three (25%) patients, the cause of pyometra was benign pathologies, among which the most common were leiomyomas (n = 2, 66.6%). CONCLUSION: Pyometra diagnosed during the post-menopausal period should be considered a complication caused by gynecological malignancy until proven otherwise.


Subject(s)
Cervix Uteri/pathology , Endometrial Neoplasms/complications , Leiomyoma/complications , Leiomyosarcoma/complications , Pyometra/etiology , Uterine Cervical Neoplasms/complications , Uterine Cervical Neoplasms/pathology , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Biopsy , Dilatation and Curettage , Female , Humans , Middle Aged , Postmenopause , Pyometra/drug therapy , Pyometra/surgery
5.
J Obstet Gynaecol ; 35(2): 178-82, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25111828

ABSTRACT

Our aim was to evaluate serum levels of anti-Müllerian hormone (AMH) and also immunohistochemical (IHC) staining properties of AMH receptor type II (AMHRII) in patients with endometrial cancer (EC) and a control group. Preoperatively, serum levels of AMH were assessed and AMHRII expression was evaluated by immunohistochemistry in a benign and malignant group. AMH serum levels of the control group and EC patients were comparable. For EC patients, there was no difference with respect to the AMH levels and tumour stage; grade; histological type; deep myometrial invasion; lymphovascular space invasion or lymph node involvement. However, AMH levels in patients with extrauterine involvement were higher than patients with disease confined to the uterus. EC samples were more likely to be stained positive for AMHRII than benign lesions. Also, as the stage of the lesion worsens, the rate of IHC staining of AMHRII decreases. In conclusion, AMHRII is expressed in normal endometrial cells as well as endometrial cancer cells. AMH levels increase in EC, with extrauterine involvement at least in locally advanced disease. Also AMH expression decreases as the disease is staged-up.


Subject(s)
Anti-Mullerian Hormone/blood , Carcinoma, Endometrioid/blood , Carcinoma, Papillary/blood , Carcinosarcoma/blood , Endometrial Neoplasms/blood , Endometrial Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Carcinoma, Endometrioid/secondary , Carcinoma, Papillary/secondary , Carcinosarcoma/secondary , Case-Control Studies , Endometrial Neoplasms/chemistry , Endometrium/chemistry , Female , Humans , Middle Aged , Neoplasm Grading , Neoplasm Invasiveness , Neoplasm Staging , Prospective Studies , Receptors, Peptide/analysis , Receptors, Transforming Growth Factor beta/analysis
6.
J Obstet Gynaecol ; 35(6): 561-4, 2015.
Article in English | MEDLINE | ID: mdl-25409325

ABSTRACT

More than half of pregnant women suffer from nausea and vomiting, in 0.5-1% of the pregnant women, if nausea and vomiting are severe and persistent, condition can progress to hyperemesis. We evaluated the fluid volume parameters in pregnant women with hyperemesis gravidarum, before and after treatment using the bioelectrical impedance vectors. A total of 70 pregnant women who had weight loss exceeding 5% of pre-pregnancy body weight were recruited for the study in the first trimester. The measurement of multi-frequency bioelectrical impedance analysis parameters was performed on the day of hospitalisation before any treatment and after treatment at 24 h and 72 h with the same procedure. Total body water, extracellular water, intracellular water, and fat-free mass index increased after treatment at 24 h (P < 0.01). Also, the mean pregnancy-unique quantification of emesis and nausea score was significantly lower after treatment (11.3 ± 2.1 at enrolment, 5.1 ± 1.4 at 24 h and 4.3 ± 1.1 at 72 h) (P < 0.01), which correlated with the patients' clinical improvement and changes in hydration. In pregnant women with moderate-to-severe hyperemesis gravidarum, significant body composition changes occur and fluid replacement therapy performed during a short period of time, such as 24 h, provides improvement in body composition.


Subject(s)
Body Composition , Electric Impedance , Hyperemesis Gravidarum/physiopathology , Hyperemesis Gravidarum/therapy , Adult , Body Water , Extracellular Fluid , Female , Fluid Therapy , Humans , Intracellular Fluid , Pregnancy , Pregnancy Trimester, First , Weight Loss
7.
J Obstet Gynaecol ; 35(3): 287-9, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25140836

ABSTRACT

The aim of this prospective study was to investigate the effect of drainage on postoperative shoulder and abdominal pain after uncomplicated laparoscopic ovarian cystectomy (LOC). Allocation to drain or not to drain was non-randomised. There were 55 patients with drainage and 56 patients without drainage. Postoperative shoulder and abdominal pain was assessed using a 10-point visual analogue scale. Postoperative hospital stay in the drainage group was longer than the non-drainage group (p = 0.040). Postoperative shoulder pain scores at 6 h and 24 h were similar between the drainage and non-drainage groups (p = 0.376 and p = 0.847, respectively). Postoperative abdominal pain was higher in the drainage group at 6 h (p = 0.009), but was similar at 24 h (p = 0.097) between the groups. These data suggest that for LOC, drainage may not be useful to prevent postoperative shoulder pain and also increases postoperative abdominal pain and length of hospital stay.


Subject(s)
Abdominal Pain/prevention & control , Drainage , Laparoscopy/adverse effects , Ovarian Cysts/surgery , Pain, Postoperative/prevention & control , Shoulder Pain/prevention & control , Adult , Female , Humans , Length of Stay , Pain Measurement , Pain, Postoperative/etiology , Prospective Studies , Young Adult
8.
J Obstet Gynaecol ; 35(5): 494-8, 2015.
Article in English | MEDLINE | ID: mdl-25325342

ABSTRACT

Post-operative ileus is a major complication that increases the morbidity in patients who had abdominal surgery. Several different procedures have been used to manage bowel function, including adequate pain control, prokinetic drugs and supportive strategies. The present study aimed to assess the effect of chewing gum on bowel recovery in patients undergoing gynaecologic abdominal surgeries. A total of 137 patients were randomised into gum-chewing and control groups. Patients in the gum-chewing group began chewing gum at post-operative 3rd h and chewed gum thereafter every 4 h daily, for 30 min each time. All patients received the same post-operative treatment. Primary outcome measures were the time to first passage of flatus and time to first passage of stool. The secondary outcome measures included the first hearing of normal bowel sounds, nausea and the time until discharge from the hospital. Compared with the control group, the time interval between operation and first flatus was shorter in the gum-chewing group (median, 33 h vs 30 h). However, the difference was not significant (p = 0.381). The first defaecation time was significantly shorter in the gum-chewing group. The median time to first defaecation was 67 (20-105) h in the control group and 45 (12-97) h in the gum-chewing group (p < 0.01). Gum chewing is safe, well tolerated and it allows early defaecation after gynaecologic abdominal surgery.


Subject(s)
Chewing Gum , Defecation , Gynecologic Surgical Procedures/rehabilitation , Adult , Humans , Middle Aged
9.
Eur J Obstet Gynecol Reprod Biol ; 180: 56-60, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25020276

ABSTRACT

OBJECTIVE: The aim of the present study was to evaluate serum concentrations of metastin in relation with hormonal and metabolic profile in patients with and without polycystic ovary syndrome (PCOS). STUDY DESIGN: The study was a clinical study. Eighty-three women with PCOS and 66 body mass index (BMI) matched controls were divided into two groups, based on BMI: overweight and obese (BMI≥25 kg/m(2)) and normal weight. (BMI<25 kg/m(2)) Hirsutism scores, hormonal and metabolic profile as well as metastin levels were evaluated in each subject. Blood samples were collected in the early follicular phase (between day 2 and day 5 of the menstrual cycle) at 9:00 AM, after an overnight fast. Circulating levels of LH, FSH, PRL, TSH, T, fT, DHEAS, 17-OH-P, sex hormone-binding globulin (SHBG), insulin, glucose, lipid profile and metastin were measured. RESULTS: Metastin levels were significantly higher in the PCOS group compared to controls (2.02 ng/ml versus 1.16 ng/ml, p<0.001). Metastin levels correlated significantly positively with luteinizing hormone (LH), total testosterone (T), dehydroepiandrosteronesulphate (DHEA-SO4) levels, modified Ferriman-Gallwey (mFG) scores and free androgen index (FAI); however, correlated negatively with sex hormone binding globulin (SHBG) levels (p<0.05). When overweight or obese (BMI≥25 kg/m(2)) and normal weight (BMI<25 kg/m(2)) women with PCOS were compared to body mass index (BMI) matched controls, higher metastin levels were also found in PCOS groups (1.94 ng/ml versus 1.18 ng/ml, and 2.06 ng/ml versus 1.08 ng/ml, p<0.05, respectively). CONCLUSIONS: These findings suggest that metastin levels were higher in women with PCOS as compared to controls regardless of BMI. Furthermore, metastin levels can be used as a specific marker for androgenic profile and this marker might play a role in the pathogenesis of PCOS.


Subject(s)
Kisspeptins/blood , Obesity/blood , Polycystic Ovary Syndrome/blood , Adolescent , Adult , Blood Glucose , Case-Control Studies , Dehydroepiandrosterone Sulfate/blood , Female , Follicle Stimulating Hormone/blood , Hirsutism/etiology , Humans , Insulin Resistance , Lipids/blood , Luteinizing Hormone/blood , Obesity/complications , Overweight/blood , Overweight/complications , Polycystic Ovary Syndrome/complications , Prolactin/blood , Sex Hormone-Binding Globulin/metabolism , Testosterone/blood , Thyrotropin/blood , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...